NAT 200 Pill - peach round, 10mm
Pill with imprint NAT 200 is Peach, Round and has been identified as Sorafenib 200 mg. It is supplied by Mylan Pharmaceuticals Inc.
Sorafenib is used in the treatment of Hepatocellular Carcinoma; Thyroid Cancer; Renal Cell Carcinoma; Hepatic Tumor and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sorafenib 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NAT 200
Sorafenib
- Imprint
- NAT 200
- Strength
- 200 mg
- Color
- Peach
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-1201
More about sorafenib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (15)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
